超支化聚甘油包覆可降解纳米粒增强瘤内递送免疫调节剂MPLA
研究将Toll样受体4激动剂单磷酸脂质A(MPLA)封装于超支化聚甘油包覆的可降解纳米粒(NP)中,以实现药物从NP核心缓释并持续刺激抗肿瘤免疫。在恶性黑色素瘤模型中,该封装显著增强MPLA重塑肿瘤微环境的能力,较游离MPLA显著增强NK细胞与细胞毒性T细胞介导的抗肿瘤免疫,并使肿瘤引流淋巴结偏向T辅助1型反应。与局部化疗联合时可逆转免疫抑制微环境并显著改善生存。
要点
- 超支化聚甘油包覆可降解NP封装MPLA可实现缓释并减少全身副作用
- 封装MPLA较游离MPLA显著增强NK细胞和细胞毒性T细胞抗肿瘤免疫
- 与局部化疗联用可逆转免疫抑制微环境并改善生存
核心结论
- 超支化聚甘油包覆可降解纳米粒封装MPLA可增强其瘤内递送与抗肿瘤免疫疗效,并减少全身副作用。
研究设计与样本
- 在恶性黑色素瘤模型中进行临床前研究,比较游离MPLA与超支化聚甘油包覆NP封装MPLA的抗肿瘤效果。
- 将TLR4激动剂MPLA封装于超支化聚甘油包覆的可降解NP中,设计为从NP核心逐渐释放药物。
- 进一步评估超支化聚甘油-NP-MPLA与局部递送化疗药联合的效果。
主要发现
- 相对游离MPLA,超支化聚甘油包覆NP封装MPLA显著增强NK细胞和细胞毒性T细胞介导的抗肿瘤免疫反应。
- 超支化聚甘油包覆NP封装MPLA使肿瘤引流淋巴结向T辅助1型反应偏移。
- 超支化聚甘油-NP-MPLA与局部化疗联合可促使免疫抑制性肿瘤微环境向免疫原性肿瘤微环境转化,并显著改善生存。
临床怎么用
- 提示纳米粒缓释封装可能是提升MPLA等免疫调节剂瘤内应用疗效并降低全身毒性的策略。
- 在黑色素瘤模型中,MPLA与局部化疗联合的免疫微环境重塑作用值得进一步转化研究。
局限性
- 证据来自恶性黑色素瘤临床前模型,尚未提供人体研究数据。
- 原文未报告具体样本量、剂量、P值及效应量等定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunomodulatory agents have significant potential to enhance cancer treatment but have demonstrated limited efficacy beyond the preclinical setting owing to poor pharmacokinetics and toxicity associated with systemic administration. Conversely, when locally delivered, immunomodulatory agents require repeated administration to optimize immune stimulation. To overcome these challenges, we encapsulated the toll-like receptor 4 agonist monophosphoryl lipid A (MPLA) within hyperbranched polyglycerol-coated biodegradable nanoparticles (NPs) engineered for gradual drug release from the NP core, resulting in a more persistent stimulation of antitumor immune responses while minimizing systemic side effects. In a model of malignant melanoma, we demonstrate that hyperbranched polyglycerol-NP encapsulation significantly improves the antitumor efficacy of MPLA by enhancing its ability to remodel the tumor microenvironment. Relative to free MPLA, hyperbranched polyglycerol-coated NP-encapsulated MPLA significantly increased the NK cell- and cytotoxic T-cell-mediated antitumor immune response and tuned the tumor-draining lymph nodes toward a T helper 1 response. Furthermore, when combined with local delivery of a chemotherapeutic agent, hyperbranched polyglycerol-NP-MPLA induces the conversion of an immunosuppressive tumor microenvironment to immunogenic tumor microenvironment and significantly improves survival.
引用
- Chang J, Shin K, Lewis JM, et al. Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol-Coated Biodegradable Nanoparticles. J Invest Dermatol. 2024. PMID: 39122142. doi:10.1016/j.jid.2024.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。